ارزیابی پلی‌مورفیسم 49AG ژن رمزکننده CTLA-4 در بیماران مبتلا‌به لوپوس اریتماتوی سیستمیک: مطالعه مرور منظم و متاآنالیز

Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor familials. N Engl J Med 1996;334:1717-25.

Utz PJ. Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus. Lupus 2004; 13(5):304-11.

Kyogoku C, Tsuchiya N: A compass that points to lupus: genetic studies on type I interferon pathway. Genes Immun 2007;8:445-455.

Greenwald RJ, Latchman YE, Sharpe AH. Negative coreceptors on lymphocytes. Curr Opin Immunol 2002;14:391-396.

Ahmed S, Ihara K, Kanemitsu S, Nakashima H, Otsuka T, Tsuzaka K, et al. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. J Rheumatology 2001;40:662-667.

Eagar TN, Karandikar NJ, Bluestone JA, Miller SD. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Eur J Immunol 2002;32:972-981.

Parks CG, Hudson LL, Cooper GS, Dooley MA, Treadwell EL, St Clair EW, et al. CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States. J Lupus 2004;13(10):784-91.

Utz PJ. Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus. Lupus 2004;13:304-11.

Ariyan C, Salvalaggio P, Fecteau S, Deng S, Rogozinski L, Mandelbrot D, et al. Cutting edge: transplantation tolerance through enhanced CTLA- 4 expression. J Immunol 2003;171:5673-5677.

Lafage-Pochitaloff M, Costello R, Couez D, et al. Human CD28 and CTLA-4 Ig superfamily genes are located on chromosome 2 at bands q33-q34. Immunogenetics 1990;31:198-201.

Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases – a general susceptibility gene to autoimmunity?. Genes Immun 2000;1:170-184.

Ulker M, YazisizV, Sallakci N, Avci AB, Sanlioglu S, Yegin O, et al. CTLA-4 gene polymorphism of exon 1 (+ 49 A/G) in Turkish systemic lupus erythematosus patients. International Journal of Immunogenetics 2009;36:245-250.

Parks CG, Hudson LL, Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Pandey JP. CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States. J Lupus 2004;13(10):784-91.

Chua KH, Puah SM, Chew CH, Tan SN, Lian LH. Study of the CTLA-4 gene polymorphisms in systemic lupus erythematosus (SLE) samples from Malaysia. Annals of Human Biology 2010;37(2):274-280.

Ahmed S, Ihara K, Kanemitsu S, Nakashima H, Otsuka T, Tsuzaka K, et al. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. J Rheumatology 2001;40:662-667.

Heward J, Gordon C, Allahabadia A, H Barnett A, A Franklyn J, C L Gough S. The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus. Ann Rheum Dis 1999;58:193-195.

Matsushita M, Tsuchiya N, Shiota M, Komata T, Matsuta K, Zama K, et al. Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method. Tissue Antigens 1997;54:578-584.

Pullmann R Jr, Lukac J, Skerenova M, Rovensky J, Hybenova J, Melus V, et al. Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1999;17:725-729.

Barreto M, Santos E, Ferreira R, Fesel C, Fontes MF, Pereira C, et al. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur J Hum Genet 2004;12:620-626.

Takeuchi F, Kawasugi K, Nabeta H, Mori M, Tanimoto K. CTLA-4 dimorphisms in Japanese patients with systemic lupus erythematosus. Clin Exp Rheumato 2003;l)21(:527-528.

Lee YH, Choi SJ, Kim YR, Ji JD, Song GG, PM G, et al. Polymorphisms of CTLA-4 exon 1 and promoter genes in systemic lupus erythematosus and rheumatoid arthritis. J Korean Rheum Assoc 2000;7(1):53-61.

Cooper GS, Dooly MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS. Hormonal, environmental and infectious risk factor for developing systemic lupus erythematosus. Arthritis Rheum 1998;41:1714-24.

Chai HC, Phipps ME, Chua KH. Genetic risk factors of systemic lupus erythematosus in the malaysian population: A minireview. Journal of Immunology 2012;1-9.

Lee YH, Harley JB, Nath SK. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE) : a meta-analysis. Hum Genet 2005;116:361-367.

Liu MF, Wang CR, Lin LC, Wu CR. CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus. Lupus 2001;10:647-649.

Aguilar F, Torres B, Sanchez-Roman J, Nunez-Roldan A, Gonzalez-Escribano MF. CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus. Hum Immunol 2003:64:936-940.

Kimkong I, Nakkuntod J, Sae-Ngow S, SnabboonT, Avihingsanon Y, Hirankarn N. Association between CTLA-4 polymorphisms and the susceptibility to systemic lupus erythematosus and Graves’disease in Thai population. Asian Pac J Allergy Immunol 2011;29:229-35.

Hudson LL, Rocca K, Song YW, Pandey JP. CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Hum Genet 2002;111:452-455.